Taiwan's Successful COVID-19 Mitigation and Containment Strategy : Achieving Quasi Population Immunity
The authors describe Taiwan's successful strategy in achieving control of coronavirus disease (COVID-19) without economic shutdown, despite the prediction that millions of infections would be imported from travelers returning from Chinese New Year celebrations in Mainland China in early 2020. As of September 2, 2020, Taiwan reports 489 cases, 7 deaths, and no locally acquired COVID-19 cases for the last 135 days (greater than 4 months) in its population of over 23.8 million people. Taiwan created quasi population immunity through the application of established public health principles. These non-pharmaceutical interventions, including public masking and social distancing, coupled with early and aggressive identification, isolation, and contact tracing to inhibit local transmission, represent a model for optimal public health management of COVID-19 and future emerging infectious diseases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Disaster medicine and public health preparedness - 16(2022), 2 vom: 11. Apr., Seite 434-437 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chien, Li-Chien [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 14.06.2022 Date Revised 17.08.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1017/dmp.2020.357 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM314845550 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM314845550 | ||
003 | DE-627 | ||
005 | 20231225153621.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1017/dmp.2020.357 |2 doi | |
028 | 5 | 2 | |a pubmed24n1049.xml |
035 | |a (DE-627)NLM314845550 | ||
035 | |a (NLM)32912352 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chien, Li-Chien |e verfasserin |4 aut | |
245 | 1 | 0 | |a Taiwan's Successful COVID-19 Mitigation and Containment Strategy |b Achieving Quasi Population Immunity |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.06.2022 | ||
500 | |a Date Revised 17.08.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The authors describe Taiwan's successful strategy in achieving control of coronavirus disease (COVID-19) without economic shutdown, despite the prediction that millions of infections would be imported from travelers returning from Chinese New Year celebrations in Mainland China in early 2020. As of September 2, 2020, Taiwan reports 489 cases, 7 deaths, and no locally acquired COVID-19 cases for the last 135 days (greater than 4 months) in its population of over 23.8 million people. Taiwan created quasi population immunity through the application of established public health principles. These non-pharmaceutical interventions, including public masking and social distancing, coupled with early and aggressive identification, isolation, and contact tracing to inhibit local transmission, represent a model for optimal public health management of COVID-19 and future emerging infectious diseases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a Taiwan | |
650 | 4 | |a emerging infectious disease | |
650 | 4 | |a non-pharmaceutical interventions | |
700 | 1 | |a Beÿ, Christian K |e verfasserin |4 aut | |
700 | 1 | |a Koenig, Kristi L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Disaster medicine and public health preparedness |d 2007 |g 16(2022), 2 vom: 11. Apr., Seite 434-437 |w (DE-627)NLM178700665 |x 1938-744X |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2022 |g number:2 |g day:11 |g month:04 |g pages:434-437 |
856 | 4 | 0 | |u http://dx.doi.org/10.1017/dmp.2020.357 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2022 |e 2 |b 11 |c 04 |h 434-437 |